LRRN3 and neuroblastoma: Chou et al. (2013) found that reduced LRRN3 gene expression correlates with the senescent phenotype of CD8 + T cells. In neuroblastomas, low expression of LRRN3 is associated with a lower survival rate (Akter et al., 2011).